Wolverine Asset Management LLC Pfizer Inc Call Options Transaction History

Wolverine Asset Management LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 04, 2024	SELL	$27.7 - $31.39 $481,980 - $546,186	-17,400 Reduced 24.1%	54,800 $1.59 Million
Q2 2024 Aug 01, 2024	BUY	$25.26 - $29.6 $181,872 - $213,120	7,200 Added 11.08%	72,200 $2.02 Million
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $5.59 Million - $6.42 Million	-216,100 Reduced 76.88%	65,000 $1.8 Million
Q4 2023 Feb 01, 2024	BUY	$26.13 - $33.94 $2.7 Million - $3.5 Million	103,200 Added 58.01%	281,100 $8.09 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $99,479 - $116,281	-3,100 Reduced 1.71%	177,900 $5.9 Million
Q2 2023 Aug 07, 2023	SELL	$36.12 - $41.79 $408,156 - $472,227	-11,300 Reduced 5.88%	181,000 $6.64 Million
Q1 2023 May 08, 2023	BUY	$39.39 - $51.28 $3.79 Million - $4.94 Million	96,300 Added 100.31%	192,300 $7.85 Million
Q4 2022 Feb 01, 2023	BUY	$41.75 - $54.5 $3.91 Million - $5.1 Million	93,600 Added 3900.0%	96,000 $4.92 Million
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $105,024 - $128,208	2,400 New	2,400 $105,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.